May 28, 2012

CAS databases provide millions of journal article references from more than 10,000 major scientific journals worldwide, patent and patent family references from 63 patent authorities around the world, and other reputable web sources.

The following patent record is from the CAplusSM database.

CAPLUS COPYRIGHT 2012 ACS

Patent Number: US 8153810
Title: Alkylidene complexes of ruthenium with N-heterocyclic carbene ligands and their application as highly active, selective catalysts for olefin metathesis
Inventor(s): Herrmann, Wolfgang Anton; Schattenmann, Wolfgang; Weskamp, Thomas
Patent Assignee(s): Aventis Research and Technologies G.m.b.H. and Co. K.-G., Germany; Evonik Degussa G.m.b.H.
Source: Ger. Offen., 12 pp. CODEN: GWXXBX
Language: German

Abstract:
Six title compds. were prepared in 42-89% yields and used as catalysts for polymerization and metathesis of olefins.  E.g., (Ph3P)2Cl2Ru:CHPh and 1,3-diisopropylimidazolin-2-ylidene gave 86% benzylidenedichlorobis(1,3-diisopropylimidazolin-2-ylidene)ruthenium, which, used as catalyst in ring-opening metathesis-polymerization (ROMP) of cyclooctene, gave 97% of product.

Please note:  Titles and abstracts for patent records in CAplus are routinely enhanced to better describe the claimed invention. CAS indexed DE 19815275 as the first published record of the invention which included Aventis Research and Technologies and Evonik Degussa as the patent assignees.

 

View the full-text U.S. patent from USPTO.

Recent News

       
    March 17, 2015 | New Content Provides Regulatory
    Professionals with Additional Value
    
    February 9, 2015 | Major New STN Release Delivers
    Essential Biomedical and Patent Content to IP
    Professionals
    
    January 26, 2015
 | Annual MEDLINE Reload on STN
    Features Enhanced Clinical Trial Information and the
    2015 MeSH Thesaurus
                               
  
                                                                     More News >> 

 Media Contact

 Name: Rhonda Ross
 Phone: 614-447-3624                                       
 Email: cas-pr@cas.org